Ally Financial Inc vs Axogen Inc — how do they compare? Ally Financial Inc trades at $44.15 (market cap $13.32B), while Axogen Inc trades at $48.35 (market cap $2.59B). The key difference: Ally Financial Inc is far larger — about 5.1× Axogen Inc's market cap, and Ally Financial Inc pays a 2.74% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| ALLY | AXGN | |
|---|---|---|
Market Cap | $13.32B | $2.59B |
Sector | Financials | Technology |
52-Week High | $47.25 | $48.48 |
52-Week Low | $35.96 | $14.16 |
Dividend Yield | 2.74% | — |
Enterprise Value | — | $2.50B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
AXGN is trading at $46.43, up 4.69% today, with strong technical momentum and bullish moving average signals. The company reported Q2 2026 revenue growth of 23.1% to $69.7 million and raised full-year guidance to at least $279 million. Despite recent earnings misses, analyst sentiment remains overwhelmingly positive with 84% buy ratings and a $54.33 price target.
The stock presents growth potential driven by expanding nerve care platform adoption and reimbursement improvements, but faces risks from persistent net losses (-$15.7M in 2025) and high valuation multiples (P/S 9.5). Near-term performance hinges on Q3 earnings delivery and continued commercial execution amid competitive pressures.
Trailing returns across standard periods
Ally Financial Inc is a diversified financial services firm that services automotive dealers and their retail customers. The company operates as a financial holding company and a bank holding company. Its banking subsidiary, Ally Bank, caters to the direct banking market through Internet, mobile, and mail. The company reports four business segments including Automotive Finance operations, Insurance operations, Mortgage Finance operations and Corporate Finance operations.
Read more on ALLY →Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →